Literature DB >> 1836274

Cell-to-cell mediated inhibition of natural killer cell proliferation by monocytes and its regulation by histamine H2-receptors.

K Hellstrand1, S Hermodsson.   

Abstract

Human peripheral blood monocytes, recovered by counter-current centrifugal elutriation, suppressed interleukin-2 (IL-2)-induced proliferation of autologous lymphocytes, recovered from low density Percoll fractions. Cell sorting experiments, analysis of phenotype of proliferating cells, and removal of defined cellular subsets by complement cytotoxicity revealed that IL-2-induced proliferation was confined to CD3-/16+/56+ natural killer (NK) cells. Monocyte-induced suppression of NK-cell proliferation was completed within 1 h of incubation with monocytes and unrelated to the formation of prostaglandins or other intermediary factors. The biogenic amine histamine, acting via H2-type histamine receptors (H2R) on monocytes, completely counteracted the monocyte-mediated suppression of IL-2-induced NK-cell proliferation. Our data are suggestive of a H2R-regulated, cell-cell-mediated mechanism by which monocytes down-modulate NK-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836274     DOI: 10.1111/j.1365-3083.1991.tb01599.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Human monocytes accelerate proliferation and blunt differentiation of preadipocytes in association with suppression of C/EBPΑ mRNA.

Authors:  Jacob Couturier; Sanjeet G Patel; Dinakar Iyer; Ashok Balasubramanyam; Dorothy E Lewis
Journal:  Obesity (Silver Spring)       Date:  2011-08-25       Impact factor: 5.002

Review 2.  Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

Authors:  K Hellstrand; M Brune; C Dahlgren; M Hansson; S Hermodsson; P Lindnér; U H Mellqvist; P Naredi
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

3.  Histamine in immunotherapy of advanced melanoma: a pilot study.

Authors:  K Hellstrand; P Naredi; P Lindner; K Lundholm; C M Rudenstam; S Hermodsson; M Asztély; L Hafström
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

4.  Histamine-stimulated expression of insulin-like growth factors in human glioma cells.

Authors:  L T Van der Ven; S C Van Buul-Offers; T Gloudemans; P J Roholl; J S Sussenbach; W Den Otter
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma.

Authors:  F Donskov; M Middleton; K Fode; P Meldgaard; W Mansoor; J Lawrance; N Thatcher; H Nellemann; H von der Maase
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

Review 6.  Mast Cells: A New Frontier for Cancer Immunotherapy.

Authors:  Jake N Lichterman; Sangeetha M Reddy
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.